Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Cited by (1,606)

Items 901–1,000 of 1,606

1. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline
   Miller, S L, Fenstermacher, E, Bates, J, Blacker, D, Sperling, R A, Dickerson, B C · 2007 · Journal of Neurology, Neurosurgery & Psychiatry
2. The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
   Wu, Moxin, Zhang, Manqing, Yin, Xiaoping, Chen, Kai, Hu, Zhijian, Zhou, Qin, Cao, Xianming, Chen, Zhiying, Liu, Dan · 2021 · Translational Neurodegeneration
3. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
   Michael Walter Weiner, Dallas P. Veitch, Paul S. S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Jesse M. Cedarbaum, Michael Donohue, Robert C. Green, Danielle J. Harvey, Clifford R. Jack et al. · 2015 · Alzheimer s & Dementia
4. Curli biogenesis: Order out of disorder
   Margery L. Evans, Matthew R. Chapman · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
5. Targeting Hsp90/Hsp70-Based Protein Quality Control for Treatment of Adult Onset Neurodegenerative Diseases
   William B. Pratt, Jason E. Gestwicki, Yoichi Osawa, Andrew P. Lieberman · 2014 · The Annual Review of Pharmacology and Toxicology
6. Zebrafish: an emerging real-time model system to study Alzheimer’s disease and neurospecific drug discovery
   Suraiya Saleem, Rajaretinam Rajesh Kannan · 2018 · Cell Death Discovery
7. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
   Khalid Iqbal, Inge Grundke · 2008 · Journal of Cellular and Molecular Medicine
8. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia
   William W. Seeley · 2008 · Current Opinion in Neurology
9. In Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers
   Steve Simoneau, Human Rézaei, Nicole Salès, Gunnar Kaiser-Schulz, Maxime Lefebvre-Roque, Catherine Vidal, J. G. Fournier, Julien Comte, Franziska Wopfner, Jeanne Grosclaude et al. · 2007 · PLoS Pathogens
10. Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease
    Alexander J. Ehrenberg, Austin K. Nguy, Panos Theofilas, Sara Rose Dunlop, Cláudia Kimie Suemoto, Ana Tereza Di Lorenzo Alho, Renata P. Leite, Roberta Diehl Rodriguez, Maria B. Mejia, Udo Rüb et al. · 2017 · Neuropathology and Applied Neurobiology
11. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis
    Jessica T. Root, Paola Merino, Austin Nuckols, Michelle A. Johnson, Thomas L. Kukar · 2021 · Neurobiology of Disease
12. Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation
    Jin, Meihua, Shiwaku, Hiroki, Tanaka, Hikari, Obita, Takayuki, Ohuchi, Sakurako, Yoshioka, Yuki, Jin, Xiaocen, Kondo, Kanoh, Fujita, Kyota, Homma, Hidenori et al. · 2021 · Nature Communications
13. The Association of Tau With Mitochondrial Dysfunction in Alzheimer’s Disease
    Cheng, Ying, Bai, Feng · 2018 · Frontiers in Neuroscience
14. Rare genetic mutations shed light on the pathogenesis of Parkinson disease
    Ted M. Dawson, Valina Lynn Dawson · 2003 · Journal of Clinical Investigation
15. Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum
    David Thomas Jones, Jonathan Graff‐Radford, Val J. Lowe, Heather J. Wiste, Jeffrey L. Gunter, Matthew L. Senjem, Hugo Botha, Kejal Kantarci, Bradley F. Boeve, David S. Knopman et al. · 2017 · Cortex
16. The role of mTOR signaling in Alzheimer disease
    Salvatore Oddo · 2012 · Frontiers in Bioscience-Scholar
17. Mitochondrial permeability transition pore in Alzheimer's disease: Cyclophilin D and amyloid beta
    Heng Du, Shirley ShiDu Yan · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
18. Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease
    Jankowsky, Joanna L, Slunt, Hilda H, Gonzales, Victoria, Savonenko, Alena V, Wen, Jason C, Jenkins, Nancy A, Copeland, Neal G, Younkin, Linda H, Lester, Henry A, Younkin, Steven G et al. · 2005 · PLoS Medicine
19. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer’s disease
    Urbanc, B., Cruz, L., Le, R., Sanders, J., Ashe, K. Hsiao, Duff, K., Stanley, H. E., Irizarry, M. C., Hyman, B. T. · 2002 · Proceedings of the National Academy of Sciences
20. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
    Mattsson, Niklas, Insel, Philip S., Donohue, Michael, Landau, Susan, Jagust, William J., Shaw, Leslie M., Trojanowski, John Q., Zetterberg, Henrik, Blennow, Kaj, Weiner, Michael W. · 2015 · Brain
21. Drosophila melanogaster in the Study of Human Neurodegeneration
    Frank Hirth · 2010 · CNS & Neurological Disorders - Drug Targets
22. Elucidation of Amyloid β-Protein Oligomerization Mechanisms: Discrete Molecular Dynamics Study
    Brigita Urbanc, Mark Betnel, Luis Cruz, Gal Bitan, David B. Teplow · 2010 · Journal of the American Chemical Society
23. Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy
    Jinghui Song, Jin‐Tai Yu, Lan Tan · 2014 · Molecular Neurobiology
24. Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
    Rebecca Craig‐Schapiro, Max Kühn, Chengjie Xiong, Eve H. Pickering, Jingxia Liu, Thomas P. Misko, Richard J. Perrin, Kelly R. Bales, Holly D Soares, Anne M. Fagan et al. · 2011 · PLoS ONE
25. Bioactivity of Olive Oil Phenols in Neuroprotection
    Cristina Angeloni, Marco Malaguti, Maria Cristina Barbalace, Silvana Hrelia · 2017 · International Journal of Molecular Sciences
26. Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers
    Potter, Rachel, Patterson, Bruce W., Elbert, Donald L., Ovod, Vitaliy, Kasten, Tom, Sigurdson, Wendy, Mawuenyega, Kwasi, Blazey, Tyler, Goate, Alison, Chott, Robert et al. · 2013 · Science Translational Medicine
27. Neuroprotective Natural Products for Alzheimer’s Disease
    Chen, Xin, Drew, Joshua, Berney, Wren, Lei, Wei · 2021 · Cells
28. Microglia and Alzheimer’s Disease
    Merighi, Stefania, Nigro, Manuela, Travagli, Alessia, Gessi, Stefania · 2022 · International Journal of Molecular Sciences
29. Mechanisms of Alzheimer’s Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors
    Sayad Kocahan, Zümrüt Doğan · 2017 · Clinical Psychopharmacology and Neuroscience
30. The role of NLRP3-CASP1 in inflammasome-mediated neuroinflammation and autophagy dysfunction in manganese-induced, hippocampal-dependent impairment of learning and memory ability
    Diya Wang, Jianbin Zhang, Wenkai Jiang, Zipeng Cao, Fang Zhao, Tongjian Cai, Michael Aschner, Wenjing Luo · 2017 · Autophagy
31. A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies
    Miranda E. Orr, Anna Campbell Sullivan, Bess E Frost · 2017 · Trends in Pharmacological Sciences
32. Neuronal cell death mechanisms in Alzheimer’s disease: An insight
    Parul Goel, Sasanka Chakrabarti, Kapil Goel, Karanpreet Bhutani, Tanya Chopra, Sharadendu Bali · 2022 · Frontiers in Molecular Neuroscience
33. Interplay of pathogenic forms of human tau with different autophagic pathways
    Caballero, Benjamin, Wang, Yipeng, Diaz, Antonio, Tasset, Inmaculada, Juste, Yves Robert, Stiller, Barbara, Mandelkow, Eva‐Maria, Mandelkow, Eckhard, Cuervo, Ana Maria · 2018 · Aging Cell
34. Analyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
    Dorostkar, Mario M., Zou, Chengyu, Blazquez-Llorca, Lidia, Herms, Jochen · 2015 · Acta Neuropathologica
35. Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics
    Shannon L. Bianchi, Thuy Tran, ChuiLiang Liu, Susan S. Lin, Yujuan Li, Jason M. Keller, Roderic G. Eckenhoff, Maryellen Fazen Eckenhoff · 2007 · Neurobiology of Aging
36. Neurodegeneration with Tau Accumulation in a Transgenic Mouse Expressing V337M Human Tau
    K. Tanemura, M. Murayama, T. Akagi, T. Hashikawa, T. Tominaga, M. Ichikawa, H. Yamaguchi, A. Takashima · 2002 · Journal of Neuroscience
37. Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments
    Zhu, Ling-Qiang, Wang, Shao-Hui, Liu, Dan, Yin, Yang-Yang, Tian, Qing, Wang, Xiao-Chuan, Wang, Qun, Chen, Jian-Guo, Wang, Jian-Zhi · 2007 · The Journal of Neuroscience
38. Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer’s disease pathology and cognitive symptoms
    Li, Peipei, Marshall, Lee, Oh, Gabriel, Jakubowski, Jennifer L., Groot, Daniel, He, Yu, Wang, Ting, Petronis, Arturas, Labrie, Viviane · 2019 · Nature Communications
39. Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer’s Disease
    Shal, Bushra, Ding, Wei, Ali, Hussain, Kim, Yeong S., Khan, Salman · 2018 · Frontiers in Pharmacology
40. Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats
    Jun Zhang, Kai-Fu Ke, Zhan Liu, Yi-Hua Qiu, Yu-Ping Peng · 2013 · PLoS ONE
41. Targeting Neuroinflammation to Treat Alzheimer’s Disease
    Alberto Ardura-Fabregat, Erik Boddeke, Antonio Boza‐Serrano, Simone Brioschi, Sergio Castro‐Gomez, Kelly Ceyzériat, Cira Dansokho, Tobias Dierkes, Géraldine Gelders, Michael Thomas Heneka et al. · 2017 · CNS Drugs
42. The neuroprotective role of melatonin in neurological disorders
    Badrah Saeed Ali Alghamdi · 2018 · Journal of Neuroscience Research
43. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease
    Sriram Balusu, Katrien Horré, Nicola Thrupp, Katleen Craessaerts, An Snellinx, Lutgarde Serneels, Dries T’Syen, Iordana Chrysidou, Amaia M. Arranz, Annerieke S. R. Sierksma et al. · 2023 · Science
44. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease.
    Brandy L. Wilkinson, Gary E. Landreth · 2006 · Journal of Neuroinflammation
45. IgG-Assisted Age-Dependent Clearance of Alzheimer's Amyloid β Peptide by the Blood–Brain Barrier Neonatal Fc Receptor
    Rashid Deane, Abhay P. Sagare, Katie Hamm, Margaret Parisi, Barbra LaRue, Huang Guo, Zhenhua Wu, David M. Holtzman, Berislav V. Zloković · 2005 · Journal of Neuroscience
46. Alzheimer's Disease-Like Pathology Induced by Amyloid-β Oligomers in Nonhuman Primates
    Letícia Forny‐Germano, Natalia M. Lyra e Silva, André F. Batista, Jordano Brito‐Moreira, Matthias Gralle, Susan E. Boehnke, Brian C. Coe, Ann Lablans, Suelen Adriani Marques, Ana Maria Blanco Martinez et al. · 2014 · Journal of Neuroscience
47. Statins for the treatment of dementia
    Bernadette McGuinness, David Craig, Roger Alan Bullock, Reem Saleem Malouf, Peter Passmore · 2014 · Cochrane Database of Systematic Reviews
48. The dynamics of monocytes and microglia in Alzheimer’s disease
    Peter Thériault, Ayman ElAli, Serge Rivest · 2015 · Alzheimer s Research & Therapy
49. Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin
    Milan Fiala, Philip T. Liu, Araceli Espinosa de los Monteros, Mark J. Rosenthal, George W. Bernard, John Matthew Ringman, James William Sayre, Laura Zhang, Justin Zaghi, Sheila Dejbakhsh et al. · 2007 · Proceedings of the National Academy of Sciences
50. Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
    Sangyun Jeong · 2017 · Molecules and Cells
51. Markers of axonal injury in post mortem human brain
    Sherriff, F. E., Bridges, L. R., Gentleman, S. M., Sivaloganathan, S., Wilson, S. · 1994 · Acta Neuropathologica
52. Increased CSF neurogranin concentration is specific to Alzheimer disease
    Wellington, Henrietta, Paterson, Ross W., Portelius, Erik, Törnqvist, Ulrika, Magdalinou, Nadia, Fox, Nick C., Blennow, Kaj, Schott, Jonathan M., Zetterberg, Henrik · 2016 · Neurology
53. Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation
    Wilcock, Donna M., DiCarlo, Giovanni, Henderson, Debbi, Jackson, Jennifer, Clarke, Keisha, Ugen, Kenneth E., Gordon, Marcia N., Morgan, Dave · 2003 · The Journal of Neuroscience
54. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway
    Vukic, Vanja, Callaghan, Debbie, Walker, Douglas, Lue, Lih-Fen, Liu, Qing Yan, Couraud, Pierre-Oliver, Romero, Ignacio A., Weksler, Babette, Stanimirovic, Danica B., Zhang, Wandong · 2009 · Neurobiology of Disease
55. Molecular biomarkers of Alzheimer's disease: progress and prospects
    Tammaryn Lashley, Jonathan M. Schott, Philip S.J. Weston, Christina E. Murray, Henny Wellington, Ashvini Keshavan, Sandrine C. Foti, Martha S. Foiani, Jamie Toombs, Jonathan Daniel Rohrer et al. · 2018 · Disease Models & Mechanisms
56. AMPK: Potential Therapeutic Target for Ischemic Stroke
    Shuai Jiang, Tian Xiang Li, Ting Ji, Wei Yi, Zhi Ping Yang, Simeng Wang, Yang Yang, Chunhu Gu · 2018 · Theranostics
57. Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease
    Sun, Binggui, Zhou, Yungui, Halabisky, Brian, Lo, Iris, Cho, Seo-Hyun, Mueller-Steiner, Sarah, Devidze, Nino, Wang, Xin, Grubb, Anders, Gan, Li · 2008 · Neuron
58. d-serine levels in Alzheimer’s disease: implications for novel biomarker development
    Caroline Madeira, Mychael V. Lourenco, Charles Vargas-Lopes, Cláudia Kimie Suemoto, Carlos Otávio Brandão, Taylor Reis, Renata Elaine Paraízo Leite, Jerson Laks, W Jacob-Filho, Carlos Augusto Pasqualucci et al. · 2015 · Translational Psychiatry
59. Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
    Amir H. Meghdadi, Marija Stevanović Karić, Marissa McConnell, Greg Rupp, Christian Richard, Joanne M. Hamilton, David H. Salat, Chris Berka · 2021 · PLoS ONE
60. Beta‐amyloid deposition and the aging brain
    Rodrigue, Karen M., Kennedy, Kristen M., Park, Denise C. · 2009 · Neuropsychology Review
61. Alzheimer's Disease Aβ Vaccine Reduces Central Nervous System Aβ Levels in a Non-Human Primate, the Caribbean Vervet
    Lemere, Cynthia A., Beierschmitt, Amy, Iglesias, Melitza, Spooner, Edward T., Bloom, Jeanne K., Leverone, Jodi F., Zheng, Jessica B., Seabrook, Timothy J., Louard, Dora, Li, Diana et al. · 2004 · The American Journal of Pathology
62. Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?
    Rory J Kelleher, Roy Louis Soiza · 2013 · Europe PMC (PubMed Central)
63. Calcineurin Triggers Reactive/Inflammatory Processes in Astrocytes and Is Upregulated in Aging and Alzheimer's Models
    Norris, Christopher M., Kadish, Inga, Blalock, Eric M., Chen, Kuey-Chu, Thibault, Veronique, Porter, Nada M., Landfield, Philip W., Kraner, Susan D. · 2005 · The Journal of Neuroscience
64. Targeting the Synapse in Alzheimer’s Disease
    Jackson, Johanna, Jambrina, Enrique, Li, Jennifer, Marston, Hugh, Menzies, Fiona, Phillips, Keith, Gilmour, Gary · 2019 · Frontiers in Neuroscience
65. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer’s disease-specific changes in the human cortex
    Gasparoni, Gilles, Bultmann, Sebastian, Lutsik, Pavlo, Kraus, Theo F. J., Sordon, Sabrina, Vlcek, Julia, Dietinger, Vanessa, Steinmaurer, Martina, Haider, Melanie, Mulholland, Christopher B. et al. · 2018 · Epigenetics & Chromatin
66. Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease
    Xueli Zhang, Yanli Tian, Can Martin Zhang, Xiaoyu Tian, Alana Ross, Robert D. Moir, Hongbin Sun, Rudolph E. Tanzi, Anna V. Moore, Chongzhao Ran · 2015 · Proceedings of the National Academy of Sciences
67. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series
    Jon A. Beck, Jonathan Daniel Rohrer, Tracy Campbell, Adrian M. Isaacs, Karen E. Morrison, Gerald Goodall, Elizabeth K. Warrington, John Stevens, Tamás Révész, Janice L. Holton et al. · 2008 · Brain
68. Impaired Synaptic Function in the Microglial KARAP/DAP12-Deficient Mouse
    Anne Roumier, Catherine Béchade, Jean Christophe Poncer, Karl‐Heinz Smalla, Elena Tomasello, Éric Vivier, Eckart Dieter Gundelfinger, Antoine Triller, Alain Bessis · 2004 · Journal of Neuroscience
69. Brain-immune interactions in perinatal hypoxic-ischemic brain injury
    Bo Li, Katherine R. Concepcion, Xianmei Meng, Li Zhang · 2017 · Progress in Neurobiology
70. Biomarkers for tau pathology
    Michael Schöll, Anne Maaß, Niklas Mattsson, Nicholas James Ashton, Kaj Blennow, Henrik Zetterberg, William J. Jagust · 2018 · Molecular and Cellular Neuroscience
71. The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?
    Elham Razani, Atieh Pourbagheri‐Sigaroodi, Ava Safaroghli‐Azar, Anahita Zoghi, Mahsa Shanaki Bavarsad, Davood Bashash · 2021 · Cell Stress and Chaperones
72. In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline
    Heidi I.L. Jacobs, John Alex Becker, Kenneth K. Kwong, Nina Engels, Prokopis C. Prokopiou, Kathryn V. Papp, Michael J Properzi, Olivia L. Hampton, Federico d’Oleire Uquillas, Justin S. Sanchez et al. · 2021 · Science Translational Medicine
73. Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer’s disease
    Zeng, Hu, Huang, Jiahao, Zhou, Haowen, Meilandt, William J., Dejanovic, Borislav, Zhou, Yiming, Bohlen, Christopher J., Lee, Seung-Hye, Ren, Jingyi, Liu, Albert et al. · 2023 · Nature Neuroscience
74. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease
    Grassi, Diego, Howard, Shannon, Zhou, Minghai, Diaz-Perez, Natalia, Urban, Nicolai T., Guerrero-Given, Debbie, Kamasawa, Naomi, Volpicelli-Daley, Laura A., LoGrasso, Philip, Lasmézas, Corinne Ida · 2018 · Proceedings of the National Academy of Sciences
75. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders
    Chi‐Tso Chiu, De‐Maw Chuang · 2010 · Pharmacology & Therapeutics
76. Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer’s Disease
    Dan Xia, Hirotaka Watanabe, Bei Wu, Sang Hun Lee, Yan Li, Evgeny Tsvetkov, Vadim Y. Bolshakov, Jie Shen, Raymond J. Kelleher · 2015 · Neuron
77. Tau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model of Alzheimer's Disease
    T. Fath, Jochen Eidenmüller, R. Brandt · 2002 · Journal of Neuroscience
78. Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy aging
    David Clewett, Tae‐Ho Lee, Steven G. Greening, Allison Ponzio, Eshed Margalit, Mara Mather · 2015 · Neurobiology of Aging
79. Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer’s disease
    Jay Rasmussen, Jasmin Mahler, Natalie Beschörner, Stephan A. Kaeser, Lisa M. Häsler, Frank Baumann, Sofie Nyström, Erik Portelius, Kaj Blennow, Tammaryn Lashley et al. · 2017 · Proceedings of the National Academy of Sciences
80. Glial Cells Shape Pathology and Repair After Spinal Cord Injury
    Andrew D. Gaudet, Laura K. Fonken · 2018 · Neurotherapeutics
81. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer’s disease
    Rorabaugh, Jacki M, Chalermpalanupap, Termpanit, Botz-Zapp, Christian A, Fu, Vanessa M, Lembeck, Natalie A, Cohen, Robert M, Weinshenker, David · 2017 · Brain
82. Chronic Neuron-Specific Tumor Necrosis Factor-Alpha Expression Enhances the Local Inflammatory Environment Ultimately Leading to Neuronal Death in 3xTg-AD Mice
    Janelsins, Michelle C., Mastrangelo, Michael A., Park, Keigan M., Sudol, Kelly L., Narrow, Wade C., Oddo, Salvatore, LaFerla, Frank M., Callahan, Linda M., Federoff, Howard J., Bowers, William J. · 2008 · The American Journal of Pathology
83. Antimicrobial Properties of Amyloid Peptides
    Bruce L. Kagan, Hyunbum Jang, Ricardo F. Capone, Fernando Terán Arce, Srinivasan Ramachandran, Ratnesh Lal, Ruth Nussinov · 2011 · Molecular Pharmaceutics
84. Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
    Bruce A. Yankner, Tao Lu · 2008 · Journal of Biological Chemistry
85. Prevalence of Alzheimer plaques in AIDS
    Margaret M. Esiri, Simon Charles Biddolph, C. S Morris · 1998 · Journal of Neurology Neurosurgery & Psychiatry
86. In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
    Georgia Watt, Tim Karl · 2017 · Frontiers in Pharmacology
87. Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals
    Soghra Bagheri, Rosanna Squitti, Thomas Haertlé, Mariacristina Siotto, Ali Akbar Saboury · 2018 · Frontiers in Aging Neuroscience
88. On the Neuroprotective Role of Astaxanthin: New Perspectives?
    Christian Galasso, Ida Orefice, Paola Pellone, Paola Cirino, Roberta Miele, Adrianna Ianora, Christophe Brunet, Clementina Sansone · 2018 · Marine Drugs
89. Lamin Dysfunction Mediates Neurodegeneration in Tauopathies
    Frost, Bess, Bardai, Farah H., Feany, Mel B. · 2016 · Current Biology
90. High fat induces acute and chronic inflammation in the hypothalamus: effect of high-fat diet, palmitate and TNF-α on appetite-regulating NPY neurons
    Prasad S. Dalvi, Jennifer A. Chalmers, Vicky Luo, D-YD Han, Leigh Wellhauser, Ying Liu, Dean Q. Tran, Julien Castel, Serge H. Luquet, Michael B. Wheeler et al. · 2016 · International Journal of Obesity
91. The role of cell cycle‐mediated events in Alzheimer's disease
    Arun K. Raina, Mervyn J. Monteiro, Andrew McShea, Mark A. Smith · 1999 · International Journal of Experimental Pathology
92. Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease
    Schupf, Nicole, Tang, Ming X., Fukuyama, Hide, Manly, Jennifer, Andrews, Howard, Mehta, Pankaj, Ravetch, Jeffery, Mayeux, Richard · 2008 · Proceedings of the National Academy of Sciences
93. Neurons derived from sporadic Alzheimer’s disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation
    Ochalek, Anna, Mihalik, Balázs, Avci, Hasan X., Chandrasekaran, Abinaya, Téglási, Annamária, Bock, István, Giudice, Maria Lo, Táncos, Zsuzsanna, Molnár, Kinga, László, Lajos et al. · 2017 · Alzheimer's Research & Therapy
94. Generation of Aggregated β-Amyloid in the Rat Hippocampus Impairs Synaptic Transmission and Plasticity and Causes Memory Deficits
    Aline Stéphan, Serge Laroche, Sabrina Davis · 2001 · Journal of Neuroscience
95. Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's neurodegeneration
    Hong-Lian Li, Hai-Hong Wang, Shi-Jie Liu, Yan-Qiu Deng, Yong-Jie Zhang, Qing Tian, Xiao-Chuan Wang, Xiaoqian Chen, Ying Yang, Jia-Yu Zhang et al. · 2007 · Proceedings of the National Academy of Sciences
96. Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer’s disease
    Johnny Habchi, Sean Chia, Ryan Limbocker, Benedetta Mannini, Minkoo Ahn, Michele Perni, Oskar Hansson, Paolo Arosio, Janet R. Kumita, Pavan K. Challa et al. · 2016 · Proceedings of the National Academy of Sciences
97. A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model
    Munoz, Lenka, Ranaivo, Hantamalala Ralay, Roy, Saktimayee M, Hu, Wenhui, Craft, Jeffrey M, McNamara, Laurie K, Chico, Laura Wing, Van Eldik, Linda J, Watterson, D Martin · 2007 · Journal of Neuroinflammation
98. Plasma Amyloid-β as a Predictor of Dementia and Cognitive Decline
    Alain K. Koyama, Olivia I. Okereke, Ting Yang, Deborah Blacker, Dennis J. Selkoe, Francine Grodstein · 2012 · Archives of Neurology
99. Cellular and pathological heterogeneity of primary tauopathies
    Dah‐eun Chloe Chung, Shanu Faerch Roemer, Leonard Petrucelli, Dennis W. Dickson · 2021 · Molecular Neurodegeneration
100. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections
     Iba, Michiyo, McBride, Jennifer D., Guo, Jing L., Zhang, Bin, Trojanowski, John Q., Lee, Virginia M.-Y. · 2015 · Acta Neuropathologica